Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection
Mohammad Ullah Nayan, Brady Sillman, Mahmudul Hasan, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 115009-115009
Open Access | Times Cited: 22

Showing 22 citing articles:

Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques
Shery Jacob, Fathima Sheik Kather, Sai H. S. Boddu, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 136-136
Open Access | Times Cited: 1
Evaluating the Efficacy of Repurposed Antiretrovirals in Hepatitis B Virus Treatment: A Narrative Review of the Pros and Cons
Samuel Chima Ugbaja, Simon Achi Omerigwe, S Ndlovu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 925-925
Open Access | Times Cited: 1
Polymer Delivery Systems for Long-Acting Antiretroviral Drugs
Mohammad Ullah Nayan, Sudipta Panja, Ashrafi Sultana, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 183-183
Open Access | Times Cited: 5
The Phenomenon of Antiretroviral Drug Resistance in the Context of Human Immunodeficiency Virus Treatment: Dynamic and Ever Evolving Subject Matter
Miruna-Maria Apetroaei, Bruno Ștefan Velescu, Marina Ionela Nedea, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 915-915
Open Access | Times Cited: 5
D-peptide hydrogels as a long-acting multipurpose drug delivery platform for combined contraception and HIV prevention
Sreekanth Pentlavalli, Sophie Coulter, Yuming An, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 30-44
Open Access
The Optimized Lipid‐Modified Prodrug for CNV Treatment
Xinying Lv, Jingjing Shen, Xinwei Du, et al.
Advanced Materials (2025)
Closed Access
Nanotherapeutics in human immunodeficiency viruses infections
Pooja Pandita, Megha, Vibha Giri, et al.
Elsevier eBooks (2025), pp. 341-370
Closed Access
Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a Cure
Massimiliano Lanzafame, Giovanni Mori, Sandro Vento
Biomedicines (2025) Vol. 13, Iss. 2, pp. 493-493
Open Access
Highly Efficient Organic Solvent-Free Oiling-Out-Dissolving Strategy to Fabricate Aripiprazole Microcrystals for Long-Acting Antipsychotics
Lan Fang, Luyan Wang, Z. Ding, et al.
ACS Sustainable Chemistry & Engineering (2025)
Closed Access
Current insights and molecular docking studies of HIV‐1 reverse transcriptase inhibitors
Ankit Kumar Singh, Adarsh Kumar, Sahil Arora, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 10
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long‐Acting Intramuscular Injection in Real‐World People with HIV
Paul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 115, Iss. 6, pp. 1450-1459
Open Access | Times Cited: 2
New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs
Maria Marra, Alessia Catalano, Maria Stefania Sinicropi, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1484-1484
Open Access | Times Cited: 1
Interventions during Early Infection: Opening a Window for an HIV Cure?
Christopher R. Hiner, April L. Mueller, Hang Su, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1588-1588
Open Access | Times Cited: 1
Central nervous system complications of human immunodeficiency virus infection
Wenxian Zhou, Shaurav Bhattarai, Roshan Sapkota, et al.
Elsevier eBooks (2024), pp. 23-43
Closed Access
Short Cycle Therapy with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Small Cohort of Virally Suppressed People Living with HIV: A Long-Term Follow-Up
Massimiliano Lanzafame, Emanuela Lattuada, Andrea Delama, et al.
(2024)
Open Access
Nanoparticle-Based Drug Delivery for Infectious Diseases
Ashrafi Sultana, Mohammad Ullah Nayan
(2024), pp. 349-378
Closed Access
Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2
Irene Wanjiru Kiarie, Gyula Hoffka, Manon Laporte, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1607-1607
Open Access
Prolonged release and antiviral efficacy of HIV fusion inhibitor LP-98-loaded microspheres in rhesus macaques
Zhe Cong, Yi Wei, Huihui Chong, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 530-541
Open Access
Thromboembolic disease in HIV/AIDS: More attention is needed
Mengyuan Huang, Chao Chen, Bingfang Yu, et al.
Chinese Medical Journal (2024)
Open Access
Short-Cycle Therapy with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Small Cohort of Virally Suppressed People Living with HIV: A Long-Term Follow-Up
Massimiliano Lanzafame, Emanuela Lattuada, Andrea Delama, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2620-2620
Open Access
Long-acting antiretroviral therapy in low-income and middle-income countries: considerations for roll-out
Angela Tembo, François Venter, Simiso Sokhela
Current Opinion in HIV and AIDS (2024)
Closed Access
Ultra-Long-Acting Drug Delivery Formulations
Mohammad Ullah Nayan, Ashrafi Sultana, Nam Thai Hoang Le, et al.
NeuroImmune Pharmacology and Therapeutics (2024), pp. 657-670
Closed Access
Page 1

Scroll to top